1 - 25 of
42
results
for author:"Lyons P."
in Literature Citations
| Activin receptor signaling regulates prostatic epithelial cell adhesion and viability. Simon D.P., Vadakkadath Meethal S., Wilson A.C., Gallego M.J., Weinecke S.L., Bruce E., Lyons P.F., Haasl R.J., Bowen R.L., Atwood C.S. Neoplasia 11:365-376(2009) · Mapped (2) |
| Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis. Carr E.J., Clatworthy M.R., Lowe C.E., Todd J.A., Wong A., Vyse T.J., Kamesh L., Watts R.A., Lyons P.A., Smith K.G. BMC Med. Genet. 10:22-22(2009) · Mapped (7) |
| Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples. Talkowski M.E., McClain L., Allen T., Bradford L.D., Calkins M., Edwards N., Georgieva L., Go R., Gur R., Gur R. et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B:560-569(2009) · Mapped (6) |
| Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. Willcocks L.C., Lyons P.A., Clatworthy M.R., Robinson J.I., Yang W., Newland S.A., Plagnol V., McGovern N.N., Condliffe A.M., Chilvers E.R. et al. J. Exp. Med. 205:1573-1582(2008) · Mapped (3) |
| Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. Brownlie R.J., Lawlor K.E., Niederer H.A., Cutler A.J., Xiang Z., Clatworthy M.R., Floto R.A., Greaves D.R., Lyons P.A., Smith K.G. J. Exp. Med. 205:883-895(2008) · Mapped (6) |
| Characterization of carboxypeptidase A6, an extracellular matrix peptidase. Lyons P.J., Callaway M.B., Fricker L.D. J. Biol. Chem. 283:7054-7063(2008) · Mapped (1) |
| The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro. Newland S.A., Macaulay I.C., Floto A.R., de Vet E.C., Ouwehand W.H., Watkins N.A., Lyons P.A., Campbell D.R. |
| Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis. Ro H.-S., Zhang L., Majdalawieh A., Kim S.-W., Wu X., Lyons P.J., Webber C., Ma H., Reidy S.P., Boudreau A. et al. Obesity 15:288-302(2007) · UniProtKB (1) |
| Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Yamanouchi J., Rainbow D., Serra P., Howlett S., Hunter K., Garner V.E., Gonzalez-Munoz A., Clark J., Veijola R., Cubbon R. et al. Nat. Genet. 39:329-337(2007) · Mapped (11) |
| Modeling and functional analysis of AEBP1, a transcriptional repressor. Lyons P.J., Mattatall N.R., Ro H.-S. Proteins 63:1069-1083(2006) · UniProtKB (1) |
| Polymorphism discovery and association analyses of the interferon genes in type 1 diabetes. Morris G.A., Lowe C.E., Cooper J.D., Payne F., Vella A., Godfrey L., Hulme J.S., Walker N.M., Healy B.C., Lam A.C. et al. BMC Genet. 7:12-12(2006) · Mapped (18) |
| The cell surface receptor G6b, a member of the immunoglobulin superfamily, binds heparin. de Vet E.C., Newland S.A., Lyons P.A., Aguado B., Campbell R.D. |
| MAPK modulates the DNA binding of adipocyte enhancer-binding protein 1. Lyons P.J., Muise A.M., Ro H.-S. Biochemistry 44:926-931(2005) · UniProtKB (1) |
| Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. Wicker L.S., Chamberlain G., Hunter K., Rainbow D., Howlett S., Tiffen P., Clark J., Gonzalez-Munoz A., Cumiskey A.M., Rosa R.L. et al. J. Immunol. 173:164-173(2004) · Mapped (25) |
| Continued discovery of transcriptional units expressed in cells of the mouse mononuclear phagocyte lineage. Wells C.A., Ravasi T., Sultana R., Yagi K., Carninci P., Bono H., Faulkner G., Okazaki Y., Quackenbush J., Hume D.A. et al. Genome Res. 13:1360-1365(2003) · Mapped (3) |
| Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD mice. Penha-Goncalves C., Moule C., Smink L.J., Howson J., Gregory S., Rogers J., Lyons P.A., Suttie J.J., Lord C.J., Peterson L.B. et al. |
| Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., Nikaido I., Osato N., Saito R., Suzuki H. et al. Nature 420:563-573(2002) · UniProtKB (17,872) · Mapped (20,305) |
| Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse. Lyons P.A., Armitage N., Lord C.J., Phillips M.S., Todd J.A., Peterson L.B., Wicker L.S. Diabetes 50:2633-2637(2001) · Mapped (12) |
| Functional annotation of a full-length mouse cDNA collection. Kawai J., Shinagawa A., Shibata K., Yoshino M., Itoh M., Ishii Y., Arakawa T., Hara A., Fukunishi Y., Konno H. et al. Nature 409:685-690(2001) · UniProtKB (17,869) · Mapped (14,263) |
| Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation. Kim S.-W., Muise A.M., Lyons P.J., Ro H.-S. J. Biol. Chem. 276:10199-10206(2001) · UniProtKB (1) |
| NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Hill N.J., Lyons P.A., Armitage N., Todd J.A., Wicker L.S., Peterson L.B. Diabetes 49:1744-1747(2000) · Mapped (18) |
| Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Siegmund T., Armitage N., Wicker L.S., Peterson L.B., Todd J.A., Lyons P.A. Diabetes 49:1612-1616(2000) · Mapped (2) |
| The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Lyons P.A., Hancock W.W., Denny P., Lord C.J., Hill N.J., Armitage N., Siegmund T., Todd J.A., Phillips M.S., Hess J.F. et al. Immunity 13:107-115(2000) · Mapped (9) |
| Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Podolin P.L., Wilusz M.B., Cubbon R.M., Pajvani U., Lord C.J., Todd J.A., Peterson L.B., Wicker L.S., Lyons P.A. Cytokine 12:477-482(2000) · Mapped (11) |
| Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Lyons P.A., Armitage N., Argentina F., Denny P., Hill N.J., Lord C.J., Wilusz M.B., Peterson L.B., Wicker L.S., Todd J.A. |
